ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
Multiple studies in recent years have identified highly tumorigenic populations of cells that drive tumor formation. These cancer stem cells (CSCs), or tumor-initiating cells (TICs), exhibit properties of normal stem cells and are associated with resistance to current therapies. As pancreatic adenoc...
Main Authors: | Michael P Kim, Jason B Fleming, Huamin Wang, James L Abbruzzese, Woonyoung Choi, Scott Kopetz, David J McConkey, Douglas B Evans, Gary E Gallick |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3113804?pdf=render |
Similar Items
-
Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
by: Sakariassen Per, et al.
Published: (2008-02-01) -
Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
by: L. Durko, et al.
Published: (2017-01-01) -
Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”
by: L. Durko, et al.
Published: (2017-01-01) -
CD133, CD44, and ALDH1A1 as cancer stem cell markers and prognostic factors in epithelial ovarian cancer
by: Nugraha Utama Pelupessy, et al.
Published: (2019-05-01) -
Significance of CD44- and ALDH1-positive stem cells in сolorectal adenocarcinoma progression
by: M. A. Shyshkin, et al.
Published: (2020-08-01)